TY - JOUR
T1 - Interconnections between the oral and gut microbiomes
T2 - Reversal of microbial dysbiosis and the balance between systemic health and disease
AU - Khor, Brandon
AU - Snow, Michael
AU - Herrman, Elisa
AU - Ray, Nicholas
AU - Mansukhani, Kunal
AU - Patel, Karan A.
AU - Said‐al‐naief, Nasser
AU - Maier, Tom
AU - Machida, Curtis A.
N1 - Funding Information:
This laboratory program and C.A.M. were previously supported by NIH DE024317 and by the OHSU School of Dentistry. N.R. will be receiving compensatory support from the OHSU School of Dentistry for his role as student representative for the Office of Student Affairs. N.S.‐A.‐ N., and T.M. receive salary support from the OHSU School of Dentistry and C.A.M. has an emeritus faculty appointment at the OHSU School of Dentistry.B.K.: M.S., E.H., N.R., K.M. and K.P. are current students in the academic DMD program at the OHSU School of Dentistry. E.H. is a recipient of the Dean’s Student Research Fel-lowship Award from the OHSU School of Dentistry, as well as a recipient of travel awards to the Hinman Student Research Symposium. E.H. is a graduating senior who will be conducting resi-dency specialty training in orthodontics at the Mayo Clinic. K.P. received a pre‐matriculation student research award from the OHSU School of Dentistry. Special thanks are also extended to Clau-dia Lyashenko, former clinical studies coordinator, as well as research dental DS4 students, Kareem Raslan and Stephanie Ortiz, and IBDS Chair, Hui Wu, for their encouragement and support. We also thank the many students, residents and faculty who conducted and supported the original work in the laboratory. The faculty co‐authors thank K.M. and K.P. for their artistic drawings cre-ated with BioRender.com, and for the compilation and construction of tables and references. Conflicts of Interest: The authors declare no conflict of interest.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/3
Y1 - 2021/3
N2 - The human microbiota represents a complex array of microbial species that influence the balance between the health and pathology of their surrounding environment. These microorganisms impart important biological benefits to their host, such as immune regulation and resistance to pathogen colonization. Dysbiosis of microbial communities in the gut and mouth precede many oral and systemic diseases such as cancer, autoimmune‐related conditions, and inflammatory states, and can involve the breakdown of innate barriers, immune dysregulation, pro‐inflammatory sig-naling, and molecular mimicry. Emerging evidence suggests that periodontitis‐associated pathogens can translocate to distant sites to elicit severe local and systemic pathologies, which necessi-tates research into future therapies. Fecal microbiota transplantation, probiotics, prebiotics, and syn-biotics represent current modes of treatment to reverse microbial dysbiosis through the introduction of health‐related bacterial species and substrates. Furthermore, the emerging field of precision medicine has been shown to be an effective method in modulating host immune response through targeting molecular biomarkers and inflammatory mediators. Although connections between the human microbiome, immune system, and systemic disease are becoming more apparent, the complex interplay and future innovations in treatment modalities will become elucidated through continued research and cross‐disciplinary collaboration.
AB - The human microbiota represents a complex array of microbial species that influence the balance between the health and pathology of their surrounding environment. These microorganisms impart important biological benefits to their host, such as immune regulation and resistance to pathogen colonization. Dysbiosis of microbial communities in the gut and mouth precede many oral and systemic diseases such as cancer, autoimmune‐related conditions, and inflammatory states, and can involve the breakdown of innate barriers, immune dysregulation, pro‐inflammatory sig-naling, and molecular mimicry. Emerging evidence suggests that periodontitis‐associated pathogens can translocate to distant sites to elicit severe local and systemic pathologies, which necessi-tates research into future therapies. Fecal microbiota transplantation, probiotics, prebiotics, and syn-biotics represent current modes of treatment to reverse microbial dysbiosis through the introduction of health‐related bacterial species and substrates. Furthermore, the emerging field of precision medicine has been shown to be an effective method in modulating host immune response through targeting molecular biomarkers and inflammatory mediators. Although connections between the human microbiome, immune system, and systemic disease are becoming more apparent, the complex interplay and future innovations in treatment modalities will become elucidated through continued research and cross‐disciplinary collaboration.
KW - Gut microbiome
KW - Inflammatory disorders
KW - Microbial dysbiosis
KW - Oral microbiome
KW - Precision medicine
KW - Systemic health and disease
KW - Thera-peutics
UR - http://www.scopus.com/inward/record.url?scp=85101607735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101607735&partnerID=8YFLogxK
U2 - 10.3390/microorganisms9030496
DO - 10.3390/microorganisms9030496
M3 - Review article
AN - SCOPUS:85101607735
SN - 2076-2607
VL - 9
SP - 1
EP - 22
JO - Microorganisms
JF - Microorganisms
IS - 3
M1 - 496
ER -